See All Slides - tctmd.com

Slides

Presentation TCT 2022

3-Year Outcomes From the Amplatzer™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial (Amulet IDE)

Presenter: Dhanunjaya Lakkireddy

September 17, 2022

Presentation TCT 2022

TCT 257: FFR-Guided PCI Optimization Directed by High-Definition IVUS Versus Standard of Care: 2-year Results from the FFR REACT Trial

Presenter: Joost Daemen

September 17, 2022

Presentation TCT 2022

TCT 64: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – 3 Clinical Year Outcomes

Presenter: Matthias Lutz

September 17, 2022

Presentation TCT 2022

TCT 41: Timing of Complete Revascularisation Following Culprit Lesion Treatment in Primary Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.

Presenter: Kais Hyasat

September 17, 2022

Presentation TCT 2022

The role of imaging in DM patients: case presentations from ABILITY RCT

Presenter: Antonio Mangieri

September 17, 2022

Presentation TCT 2022

TCT 638: Sequential transcatheter treatment of severe mitral and aortic regurgitation with MitraClip and JenaValve Trilogy in a patient with cardiogenic shock

Presenter: Lauren Ranard

September 17, 2022

Presentation TCT 2022

TCT 616: LM Iatrogenic Perforation a deadly complication, but a new approach of treatment

Presenter: Mohammad Jaradat

September 17, 2022

Presentation TCT 2022

EVOLUT: New Trials, New Technologies (OPTIMIZE PRO and SMART)

Presenter: John Forrest

September 17, 2022

Presentation TCT 2022

The Innovative DES+DCB platform

Presenter: Fazila-Tun-Nesa Malik

September 17, 2022

Presentation TCT 2022

SAPIEN: Simpler and More Sophisticated (X4 and ALLIANCE)

Presenter: Pradeep K. Yadav

September 17, 2022

Advertisement

Slides

3-Year Outcomes From the Amplatzer™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial (Amulet IDE)

TCT 257: FFR-Guided PCI Optimization Directed by High-Definition IVUS Versus Standard of Care: 2-year Results from the FFR REACT Trial

TCT 64: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – 3 Clinical Year Outcomes

TCT 41: Timing of Complete Revascularisation Following Culprit Lesion Treatment in Primary Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.

The role of imaging in DM patients: case presentations from ABILITY RCT

TCT 638: Sequential transcatheter treatment of severe mitral and aortic regurgitation with MitraClip and JenaValve Trilogy in a patient with cardiogenic shock

TCT 616: LM Iatrogenic Perforation a deadly complication, but a new approach of treatment

EVOLUT: New Trials, New Technologies (OPTIMIZE PRO and SMART)

The Innovative DES+DCB platform

SAPIEN: Simpler and More Sophisticated (X4 and ALLIANCE)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content